Back

Gene therapy in laminopathies and DCM

13 April 2024 (09:00 - 09:15)
Organised by: Logo
Congress Presentation Part of: Hypertrophic and dilated cardiomyopathy: from molecular targets to therapy Cardiomyopathies CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Anke Tijsen

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Cellular targets for drug therapy in HCM
Doctor R. Coppini (Florence, IT)
Slides
Presentation thumbnail
Genetic basis and molecular mechanisms in dilated cardiomyopathy (DCM)
Professor J. van der Velden (Amsterdam, NL)
Slides
Presentation thumbnail
Meteorin-like regulates cardiac hypertrophy and associated metabolic plasticity during gestation and lactation
Mr A. Blasco-Roset (Barcelona, ES)
Abstract Slides

Access the full session

Session thumbnail
Hypertrophic and dilated cardiomyopathy: from molecular targets to therapy

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

13 April 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Genetic variants as determinants of outcome in Lamin A/C-related cardiac disease.
29 August 2021
thumbnail
Congress Session
New frontiers in heart failure therapies
19 May 2025
thumbnail
Congress Session
Genetics, syncope
31 March 2025
thumbnail
Congress Presentation
REALM-DCM: a phase 3, multinational, randomized, placebo-controlled study of ARRY-371797 (PF-07265803) in patients with symptomatic LMNA-related dilated cardiomyopathy
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources